» Articles » PMID: 30444315

Home Blood Pressure Control Status in 2017-2018 for Hypertension Specialist Centers in Asia: Results of the Asia BP@Home Study

Abstract

A self-measured home blood pressure (BP)-guided strategy is an effective practical approach to hypertension management. The Asia BP@Home study is the first designed to investigate current home BP control status in different Asian countries/regions using standardized home BP measurements taken with the same validated home BP monitoring device with data memory. We enrolled 1443 medicated hypertensive patients from 15 Asian specialist centers in 11 countries/regions between April 2017 and March 2018. BP was relatively well controlled in 68.2% of patients using a morning home systolic BP (SBP) cutoff of <135 mm Hg, and in 55.1% of patients using a clinic SBP cutoff of <140 mm Hg. When cutoff values were changed to the 2017 AHA/ACC threshold (SBP <130 mm Hg), 53.6% of patients were well controlled for morning home SBP. Using clinic 140 mm Hg and morning home 135 mm Hg SBP thresholds, the proportion of patients with well-controlled hypertension (46%) was higher than for uncontrolled sustained (22%), white-coat (23%), and masked uncontrolled (9%) hypertension, with significant country/regional differences. Home BP variability in Asian countries was high, and varied by country/region. In conclusion, the Asia BP@Home study demonstrated that home BP is relatively well controlled at hypertension specialist centers in Asia. However, almost half of patients remain uncontrolled for morning BP according to new guidelines, with significant country/regional differences. Strict home BP control should be beneficial in Asian populations. The findings of this study are important to facilitate development of health policies focused on reducing cardiovascular complications in Asia.

Citing Articles

Home blood pressure control and prescribing patterns of anti-hypertensive medications in a home blood pressure-based hypertension-specialized clinic in Japan: a sub-analysis of the Ohasama study.

Satoh M, Metoki H, Murakami T, Tatsumi Y, Asayama K, Kikuya M Hypertens Res. 2024; 48(1):26-36.

PMID: 39463432 PMC: 11700850. DOI: 10.1038/s41440-024-01954-7.


Early Diagnosis of Cardiovascular Diseases in the Era of Artificial Intelligence: An In-Depth Review.

Almansouri N, Awe M, Rajavelu S, Jahnavi K, Shastry R, Hasan A Cureus. 2024; 16(3):e55869.

PMID: 38595869 PMC: 11002715. DOI: 10.7759/cureus.55869.


CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial).

Truong A, Tan S, Wang G, Yip A, Egermark M, Yeung W Eur Heart J Digit Health. 2024; 5(1):41-49.

PMID: 38264697 PMC: 10802822. DOI: 10.1093/ehjdh/ztad063.


GeogRaphic and socioecoNomic Distribution of real-world Indian data of home blood pressure monitoring (GRAND Study): Study protocol for an observational study in 18 medical centers across India.

Verma N, Matsushita N, Salman E, Ohkubo T, Imai Y J Clin Hypertens (Greenwich). 2023; 25(12):1105-1134.

PMID: 37909858 PMC: 10710551. DOI: 10.1111/jch.14713.


2022 Thai Hypertension Society guidelines on home blood pressure monitoring.

Kunanon S, Roubsanthisuk W, Chattranukulchai P, Sangwatanaroj S, Ophascharoensuk V, Sitthisook S J Clin Hypertens (Greenwich). 2022; 24(9):1139-1146.

PMID: 36196468 PMC: 9532919. DOI: 10.1111/jch.14569.


References
1.
Hoshide S, Yano Y, Mizuno H, Kanegae H, Kario K . Day-by-Day Variability of Home Blood Pressure and Incident Cardiovascular Disease in Clinical Practice: The J-HOP Study (Japan Morning Surge-Home Blood Pressure). Hypertension. 2017; 71(1):177-184. DOI: 10.1161/HYPERTENSIONAHA.117.10385. View

2.
Takahashi H, Yoshika M, Yokoi T . Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7130, HEM-7320F, and HEM-7500F. Blood Press Monit. 2014; 20(2):92-7. DOI: 10.1097/MBP.0000000000000096. View

3.
Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M . The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014; 37(4):253-390. DOI: 10.1038/hr.2014.20. View

4.
Wang J, Kario K, Chen C, Park J, Hoshide S, Huo Y . Management of morning hypertension: a consensus statement of an Asian expert panel. J Clin Hypertens (Greenwich). 2018; 20(1):39-44. PMC: 8030813. DOI: 10.1111/jch.13140. View

5.
Coleman A, Freeman P, Steel S, Shennan A . Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit. 2006; 11(1):27-32. DOI: 10.1097/01.mbp.0000189788.05736.5f. View